protriptyline has been researched along with Breast Neoplasms in 1 studies
Protriptyline: Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the vast majority of in vitro pharmacogenomic studies performed to date are limited to dose-response screening upon a single viability assay endpoint." | 1.56 | High content phenotypic screening identifies serotonin receptor modulators with selective activity upon breast cancer cell cycle and cytokine signaling pathways. ( Carragher, NO; Dawson, JC; Hughes, RE; Makda, A; Munro, AF; Shepherd, E; Warchal, SJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Warchal, SJ | 1 |
| Dawson, JC | 1 |
| Shepherd, E | 1 |
| Munro, AF | 1 |
| Hughes, RE | 1 |
| Makda, A | 1 |
| Carragher, NO | 1 |
1 other study available for protriptyline and Breast Neoplasms
| Article | Year |
|---|---|
High content phenotypic screening identifies serotonin receptor modulators with selective activity upon breast cancer cell cycle and cytokine signaling pathways.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferatio | 2020 |